Nearly 23,000 U.S. physicians were surveyed about their salaries for a new report from Doximity. Respondents were also asked about AI, burnout, the ongoing physician shortage and much more.

Young M. Lee, MD, a cerebrovascular surgeon with University Medical Center New Orleans, spoke to Cardiovascular Business about his experience using the newly cleared technology.

According to a new analysis of the STS/ACC TVT Registry, redo TAVR with a self-expanding transcatheter heart valve is associated with a strong safety profile and early outcomes comparable to traditional TAVR procedures.

The KardiaMobile 6L device identified dozens of arrhythmias completely missed by conventional systems.

Tempus ECG-PH was built to flag patients who may require care for pulmonary hypertension. The company also has FDA-cleared models for detecting signs of atrial fibrillation and a low ejection fraction. 

Advocates say the shift to CCTA can translate into a broader financial impacts, with some cath labs potentially seeing margin increases of as much as 40%.

According to the Texas Medical Board, the doctor erroneously relied on a radiologist to review follow-up imaging results instead of viewing them on his own.

ACC created a Medicare payment calculator for practices to see the possible impacts on their 2027 payments.

Low-risk patients face comparable outcomes after TAVR and SAVR, researchers wrote, making it important to highlight even the smallest differences between these two approaches. 

The new recall includes multiple lots of dabigatran etexilate capsules.

A new analysis has revealed an unexpected relationship between stroke-related imaging volumes and the use of IVT and EVT treatments.

It isn’t clear how many scammers are involved in the effort, but health systems across the country are warning their patients to ignore fake messages, many of which offer a “reward” in the form of a “MyChart Medicare Kit.”